Literature DB >> 9660254

Application of a new method for analysis of exhaled gas in critically ill patients.

J K Schubert1, W P Müller, A Benzing, K Geiger.   

Abstract

OBJECTIVE: Application of a new method for analysis of exhaled gas in critically ill patients.
DESIGN: Open study.
SETTING: Surgical intensive care unit of an university hospital. PATIENTS: Thirty-seven consecutive, critically ill, mechanically ventilated patients.
INTERVENTIONS: None. MEASUREMENTS AND
RESULTS: Chemical analysis of the patient's exhaled gas was based upon substance adsorption and concentration onto activated charcoal, microwave desorption and gas chromatographic separation. Patients with acute respiratory distress syndrome (ARDS) exhaled less isoprene than those without ARDS [9.8 (8.2-21.6) vs 21.8 (13.9-41.4) nmol/m2 per min [median (95% confidence interval)], p = 0.04]. In patients who developed pulmonary infection, pentane elimination increased from 0.4 (0.0-5.4) to 2.7 (0.6-6.1, p = 0.05) nmol/m2 per min and isoprene elimination decreased from 5.2 (0-33) to 5.0 (0-17, p = 0.05) nmol/m2 per min, resulting in a significant increase in pentane/isoprene ratio from 0.1 (0-0.3) to 0.4 (0-15, p = 0.007) when compared to patients without pulmonary infection.
CONCLUSIONS: The new method allows quantitative analysis of human gas samples with low substance concentrations and is well suited for clinical studies which involve the investigation of metabolic processes in the lung and the body.

Entities:  

Mesh:

Year:  1998        PMID: 9660254     DOI: 10.1007/s001340050589

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  20 in total

Review 1.  The pulmonary physician in critical care 1: pulmonary investigations for acute respiratory failure.

Authors:  J Dakin; M Griffiths
Journal:  Thorax       Date:  2002-01       Impact factor: 9.139

Review 2.  Applying metabolomics to uncover novel biology in ARDS.

Authors:  Angela J Rogers; Michael A Matthay
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-04-11       Impact factor: 5.464

Review 3.  Diagnosis of acute respiratory distress syndrome by exhaled breath analysis.

Authors:  Lieuwe D J Bos
Journal:  Ann Transl Med       Date:  2018-01

4.  Profiling of ARDS pulmonary edema fluid identifies a metabolically distinct subset.

Authors:  Angela J Rogers; Kévin Contrepois; Manhong Wu; Ming Zheng; Gary Peltz; Lorraine B Ware; Michael A Matthay
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-03-03       Impact factor: 5.464

5.  Metabolic signatures of ARDS and ARDS heterogeneity.

Authors:  Lucile Neyton; Carolyn S Calfee
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2021-10-20       Impact factor: 6.011

6.  Robust detection of P. aeruginosa and S. aureus acute lung infections by secondary electrospray ionization-mass spectrometry (SESI-MS) breathprinting: from initial infection to clearance.

Authors:  Jiangjiang Zhu; Jaime Jiménez-Díaz; Heather D Bean; Nirav A Daphtary; Minara I Aliyeva; Lennart K A Lundblad; Jane E Hill
Journal:  J Breath Res       Date:  2013-07-18       Impact factor: 3.262

7.  New Strategies and Challenges in Lung Proteomics and Metabolomics. An Official American Thoracic Society Workshop Report.

Authors:  Russell P Bowler; Chris H Wendt; Michael B Fessler; Matthew W Foster; Rachel S Kelly; Jessica Lasky-Su; Angela J Rogers; Kathleen A Stringer; Brent W Winston
Journal:  Ann Am Thorac Soc       Date:  2017-12

Review 8.  Clinical use of exhaled volatile organic compounds in pulmonary diseases: a systematic review.

Authors:  Kim D G van de Kant; Linda J T M van der Sande; Quirijn Jöbsis; Onno C P van Schayck; Edward Dompeling
Journal:  Respir Res       Date:  2012-12-21

Review 9.  Volatile metabolites of pathogens: a systematic review.

Authors:  Lieuwe D J Bos; Peter J Sterk; Marcus J Schultz
Journal:  PLoS Pathog       Date:  2013-05-09       Impact factor: 6.823

10.  Monitoring of oxidative and metabolic stress during cardiac surgery by means of breath biomarkers: an observational study.

Authors:  Florian Pabst; Wolfram Miekisch; Patricia Fuchs; Sabine Kischkel; Jochen K Schubert
Journal:  J Cardiothorac Surg       Date:  2007-09-18       Impact factor: 1.637

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.